[{"Assets_0_Q2_USD":265187000.0,"CommonStockSharesOutstanding_0_Q2_shares":32313440.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-29129000.0,"NetIncomeLoss_1_Q2_USD":-27869000.0,"NetIncomeLoss_2_Q2_USD":-42578000.0,"StockholdersEquity_0_Q2_USD":246344000.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180801"}]